Latest News

  • White-Box Algorithms Could Invite More EEG-Based Monitoring In The OR

    Diagnostics World News | Only about a quarter of anesthesiologists delivering anesthesia to patients during surgery are monitoring unconsciousness using electroencephalography (EEG), the recording of neural activity via electrodes on the scalp. A new company spun out of MIT and MGH hopes to change that.

    Jun 23, 2021
  • Mayo May Soon Bring AI-Enabled Electrocardiograms To The Clinic

    Diagnostics World News | Researchers at the Mayo Clinic have demonstrated that a standard, 12-lead electrocardiogram (ECG)—supplemented with AI—can be a biomarker of biological age, and the gap relative to chronological age is an independent risk predictor of both all-cause and cardiovascular mortality. Artificial intelligence (AI) was used to predict biological age from ECGs.

    Jun 21, 2021
  • Miniaturized Ultrasound Technology: Taking Advantage of Accessibility, Not Compromising Quality of Care

    Diagnostics World News | Much like other technology devices, medical equipment is getting smaller. Ultrasound machines, for example, are no longer forced to live on carts that are pushed from examination room to examination room. Many can now fit in the palm of your hand and operate through Smart Phones. While the machines no longer have the same complex look and feel, training health care professionals, who will be using these devices, correctly and accurately is absolutely paramount to quality patient care.

    Jun 18, 2021
  • Gamifying Vision: How Mobile Gaming Is Tracking Vision Degradation in Patients

    Diagnostics World News | Tilak Healthcare aims to combine video games with medical expertise so that the same vision monitoring tools that are reliable and useful for doctors will be playful and fun for users. If Tilak can achieve that, the company tools will be “sticky” enough to have a longstanding impact on the healthcare process for patients.

    Jun 15, 2021
  • AI Algorithms Match Pathologists In Quantifying Tumor Cellularity

    Diagnostics World News | Artificial intelligence (AI) algorithms were recently found to perform on par with pathologists when it came to quantifying tumor cellularity, an increasingly common measure of patient response to neoadjuvant therapy for breast cancer. That was one of the key findings of the Breast Pathology Quantitative Biomarkers (BreastPathQ) Challenge.

    Jun 9, 2021
  • NIH, CDC Public Health Initiative Examines Impact of At-Home COVID-19 Testing

    Diagnostics World News | A new public health initiative is looking to determine whether widespread access to rapid at-home antigen tests can help reduce the spread of SARS-CoV-2, the virus that causes COVID-19. Dubbed “Say Yes! COVID Test,” the initiative launched by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) is zeroing in on Pitt County, N.C., and Chattanooga/Hamilton County, Tenn.

    Jun 7, 2021
  • Diagnostics Funding for Infectious Diseases, Applied NGS: Follow the Money

    Diagnostics World News | NGS turnkey diagnostics, noninvasive prenatal testing with simplified sample collection, infection disease diagnostics, and more.

    Jun 3, 2021
  • New COVID Diagnostics, Pandemic Sciences Centre Launches, New Products

    Diagnostics World News | University of Oxford launches a new Pandemic Sciences Centre, Quest Diagnostics and Paige collaborate on AI for diagnostics, new products from Waters and Essenlix Corp, and COVID updates from Advanced Biological Laboratories, Ortho Clinical Diagnostics, Thermo Fisher.

    Jun 1, 2021
  • Synthetic Data Helps AI Train To Classify Brain Tumors

    Diagnostics World News | Over the past year, Michigan Medicine and Synthetaic have been collaborating to generate synthetic data to improve the rate at which brain tumors get accurately diagnosed intraoperatively. The initiative involves using a generative adversarial network to “grow" data since large public repositories do not contain the kind of images needed to guide real-time decision-making about which surgery is best for patients.

    May 27, 2021
  • Diagnostic Host Response Tests Digging Deeper For Answers

    Diagnostics World News | Today the term “presymptomatic” is thrown into casual conversations around the dinner table, and large diagnostic companies are interested in producing products providing presymptomatic notice of infection with a pathogen. In fact, new host response bacterial-viral (HR-B/V) tests that could offer an early warning system for infections.

    May 26, 2021
  • Advanced High-End Microbiological Incubators: Protecting Test Samples, Laboratory Personnel and Public Health during the COVID-19 Pandemic

    Diagnostics World News | Diagnostic testing continues to play a vital role in protecting public health throughout the COVID-19 pandemic. However, we should not overlook the importance of using workflows that safeguard the health of medical laboratory personnel by preventing potential exposure to the SARS-CoV-2 virus. This is of utmost significance given the high volume of tests processed every day, increasing the risk to laboratory teams.

    May 24, 2021
  • New Medication Insight Reports for 23andMe+ Members On Depression Drug, Blood Thinner

    Diagnostics World News | 23andMe released two new medication insight reports last week as part of the company’s 23andMe+ membership. The two new reports provide medication insights on how a person’s CYP2C19 metabolizer profile may impact therapies with citalopram, a blood thinner, and clopidogrel, an antidepressant.

    May 20, 2021
  • New Assay Quickly Profiles Patient Immune Response In The Emergency Room

    Diagnostics World News | When patients are battling any kind of infection, the focus is invariably more on the bug in their system than their immune response to its presence. Yet overactivation of the body’s infection-fighting processes is what leads to conditions like sepsis—a leading cause of death in hospitals.

    May 19, 2021
  • Mount Sinai Moving Genomics Into Clinical Care

    Diagnostics World News | The Institute for Genomic Health at Mount Sinai Health System is launching pilot programs in the clinic based on discoveries from genomic research to evaluate their real-world utility. Where genomics data proves useful, the necessary infrastructure then gets built in terms of educating medical professionals and creating navigational paths for patients to bring that information to bear in clinical decision-making.

    May 18, 2021
  • Era of Personalized Medicine & Therapeutic Drug Monitoring in Autoimmune Diseases

    Diagnostics World News | TNF-α inhibitors have been crucial in many diseases including IBD, psoriasis, cancer, and Alzheimer’s disease, among others. What exactly are we measuring to determine drug effectiveness and how can we, as clinicians, determine if these drugs are improving patient’s symptoms?

    May 13, 2021
  • St Jude Releases Early Data on Asymptomatic Cases Among Vaccinated Healthcare Workers

    Diagnostics World News | In a research letter published last week in JAMA, St Jude Children’s Research Hospital researchers reported early findings tracking asymptomatic COVID-19 among vaccinated healthcare workers. The findings will inform both individual vaccination plans as well as institutional screening and testing programs.

    May 12, 2021
  • Ginkgo, Quest Collaborate To Expand In-School COVID-19 Pooled Testing

    Diagnostics World News | Ginkgo Bioworks has added a collaboration with Quest Diagnostics to its existing network of COVID-19 testing labs. Quest Diagnostics has capacity to perform 300,000 COVID-19 PCR tests a day; the added capacity will give Ginkgo the capacity to test all 60 million US students, teachers and staff, every week.

    May 7, 2021
  • Quidel, Abbott Begin Rollout of At-Home COVID-19 Antigen Tests

    Diagnostics World News | Quidel and Abbott have introduced at-home COVID-19 antigen tests that do not require a prescription and deliver results in just minutes. They are also completely independent of doctor oversight or reporting of results.

    May 6, 2021
  • New COVID-19 Diagnostics, Myriad Sells myPath, Nanoscale Diagnostic Sensors

    Diagnostics World News | New sequencing project looks at developmental differences, Castle Biosciences to acquire Myriad’s myPath, AI tools for cystic fibrosis detection, updates in COVID-19 diagnostics, and more new products and updates from around the industry.

    May 3, 2021
  • New Business Direction for Qlucore, Preconception Genetics, and Genome Engineering

    Diagnostics World News | New funding for rapid, easy-to-use PCR and near-patient sepsis diagnostics; a seed round for preconception genetic risk modeling; and a new business for Qlucore: cancer diagnostics.

    Apr 29, 2021